16.5
Bacterial meningitis is an inflammation of the meninges that develops when certain pathogenic bacteria cross the blood–brain barrier.
Among these bacteria, encapsulated strains of Neisseria meningitidis, a gram-negative, aerobic diplococcus, are common causative agents of meningococcal meningitis.
The infection typically begins in the nasopharynx.
The bacteria attach to the nasal epithelial cells through their Type IV pili and outer membrane proteins.
After attachment, the bacteria cross the epithelial barrier by disrupting tight junctions to enter the bloodstream.
Once in the bloodstream, the bacteria release outer membrane vesicles that contain Lipid A of the lipooligosaccharide layer.
Lipid A acts as an endotoxin, stimulating the immune system and inducing systemic inflammation and vasodilation.
During bacteremia, some bacteria evade immune clearance or survive transiently within phagocytes, facilitating dissemination to the blood–brain barrier.
Specialized adhesins help bacteria enter the cerebrospinal fluid, triggering inflammation in the meninges.
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.
Routes of Entry into the Central Nervous System
Pathogenic bacteria typically reach the meninges through hematogenous spread, direct extension, or anatomical defects. Hematogenous dissemination is the most common route, where bacteria colonize mucosal surfaces (such as the nasopharynx or gastrointestinal tract), breach the epithelial barrier, and enter the bloodstream. From there, they cross the blood–brain barrier using adhesins and invasins.
Adhesion and Invasion of Epithelial Cells
The pathogenesis of N. meningitidis begins with colonization of the nasopharyngeal epithelium. Type IV pili and specific outer membrane proteins mediate strong adhesion to epithelial cell surfaces. Once anchored, the bacteria disrupt tight junctions between epithelial cells, compromising barrier integrity. This disruption allows the bacteria to traverse the epithelial layer and gain entry into the bloodstream.
Immune Evasion and Endotoxin Release
In the bloodstream, N. meningitidis releases outer membrane vesicles containing Lipid A, a toxic component of its lipooligosaccharide (LOS) layer. Lipid A acts as an endotoxin, provoking a robust immune response characterized by cytokine release, inflammation, and vasodilation. While this inflammatory reaction contributes to disease symptoms, some bacterial cells evade immune clearance by residing within macrophages and other phagocytic cells. These immune cells inadvertently transport the bacteria to the blood–brain barrier.
Penetration of the Blood–Brain Barrier and Meningeal Inflammation
Specialized adhesins facilitate the attachment of N. meningitidis to endothelial cells of the blood–brain barrier. The bacteria then penetrate into the cerebrospinal fluid (CSF), where they multiply and trigger a strong inflammatory response. This inflammatory process, driven by immune cell recruitment and mediator release, results in swelling of the meninges and the characteristic symptoms of meningococcal meningitis, including headache, fever, and neck stiffness.
Bacterial meningitis is an inflammation of the meninges that develops when certain pathogenic bacteria cross the blood–brain barrier.
Among these bacteria, encapsulated strains of Neisseria meningitidis, a gram-negative, aerobic diplococcus, are common causative agents of meningococcal meningitis.
The infection typically begins in the nasopharynx.
The bacteria attach to the nasal epithelial cells through their Type IV pili and outer membrane proteins.
After attachment, the bacteria cross the epithelial barrier by disrupting tight junctions to enter the bloodstream.
Once in the bloodstream, the bacteria release outer membrane vesicles that contain Lipid A of the lipooligosaccharide layer.
Lipid A acts as an endotoxin, stimulating the immune system and inducing systemic inflammation and vasodilation.
During bacteremia, some bacteria evade immune clearance or survive transiently within phagocytes, facilitating dissemination to the blood–brain barrier.
Specialized adhesins help bacteria enter the cerebrospinal fluid, triggering inflammation in the meninges.
From Chapter 16:
Now Playing
Bacterial Diseases
47 Views
Bacterial Diseases
391 Views
Bacterial Diseases
176 Views
Bacterial Diseases
53 Views
Bacterial Diseases
42 Views
Bacterial Diseases
49 Views
Bacterial Diseases
60 Views
Bacterial Diseases
26 Views
Bacterial Diseases
125 Views
Bacterial Diseases
306 Views
Bacterial Diseases
159 Views
Bacterial Diseases
46 Views
Bacterial Diseases
108 Views
Bacterial Diseases
186 Views
Bacterial Diseases
263 Views